Why was Dr. Kemeny chosen to direct biotechnology management curriculum?
A longtime university lecturer conveying pharmaceutical research commercialization concepts merged with entrepreneurial discernment as principal of an esteemed venture capital firm focusing on earlystage life science investments supplies Dr. Anton Kemeny with tested insights to enrich Katz management pupils through BIOTECH complexities surrounding financial projections, IP considerations, marketing rollout and legal obligations that ambitious founders must strategically navigate while upholding ethical obligations safeguarding public health interests.